Chet R. Villa, MD
- Pediatric Cardiologist, Heart Failure & Transplantation
- Associate Professor, UC Department of Pediatrics
- chet.villa@cchmc.org
- Board Certified
About
Biography
Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.
At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.
My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.
MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007.
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.
Certification: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014.
Interests
Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support
Services and Specialties
Cardiomyopathy, Rasopathy, Cardio-Oncology, Neuromuscular Cardiology, Neuromuscular Disorders
Interests
Ventricular assist device therapy; Duchenne muscular dystrophy
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Ventricular assist device implantation in children with a mechanical valve: An ACTION registry analysis. 2025; 7:100198.
Left Atrial Phasic Function via Cardiac Magnetic Resonance Imaging in Patients with Duchenne Muscular Dystrophy. Pediatric Cardiology. 2025; 46:72-80.
Impact of inflammation and steroids on anti-coagulation in children supported on a ventricular assist device. Journal of Artificial Organs. 2024; 27:368-374.
Cardiac Histopathology in Duchenne Muscular Dystrophy Demonstrates Diffuse Fibrofatty Replacement of the Myocardium. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2024; 13:e033862.
Hypertrophic cardiomyopathy in Duchenne muscular dystrophy: a case series. Cardiology in the Young. 2024; 34:2272-2274.
Abstract 4146244: Late Gadolinium Enhancement-Derived Heart Digital Twins Non-Invasively Predict Ventricular Tachycardia Risk in Duchenne Muscular Dystrophy. Circulation. 2024; 150:a4146244.
Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy. Circulation-Arrhythmia and Electrophysiology. 2024; 17:e013114.
ACTION-ARC Pediatric and Adult Congenital Heart Disease Ventricular Assist Device Adverse Event Definitions-2023. ASAIO Journal. 2024; 70:911-919.
Refractory atrial arrhythmias in Duchenne muscular dystrophy: a case series. HeartRhythm Case Reports. 2024; 10:798-802.
612P Dystrophinopathy in ACTION; Analysis of the first 500 males enrolled in the Advanced Cardiac Therapies Improving Outcomes Network prospective dystrophinopathy registry. Neuromuscular Disorders. 2024; 43:104441.561.
From the Blog
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey